<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35624395</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2240-2993</ISSN><JournalIssue CitedMedium="Internet"><Volume>123</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Acta neurologica Belgica</Title><ISOAbbreviation>Acta Neurol Belg</ISOAbbreviation></Journal><ArticleTitle>Anti-neurofascin 186 antibody in amyotrophic lateral sclerosis: a case report.</ArticleTitle><Pagination><StartPage>703</StartPage><EndPage>704</EndPage><MedlinePgn>703-704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13760-022-01989-y</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No.68, Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No.68, Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Hong-Dong</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No.68, Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ting-Ting</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No.68, Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jian-Quan</ForeName><Initials>JQ</Initials><Identifier Source="ORCID">0000-0003-0536-1131</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No.68, Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China. myxiyi_0717@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Neurol Belg</MedlineTA><NlmUniqueID>0247035</NlmUniqueID><ISSNLinking>0300-9009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Antibody</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Neurofascin 186</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>27</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35624395</ArticleId><ArticleId IdType="doi">10.1007/s13760-022-01989-y</ArticleId><ArticleId IdType="pii">10.1007/s13760-022-01989-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA (2021) European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint Task Force-Second revision. Eur J Neurol 28(11):3556&#x2013;3583. https://doi.org/10.1111/ene.14959</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14959</ArticleId><ArticleId IdType="pubmed">34327760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Pr&#xfc;ss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, Eshed-Eisenbach Y, Peles E, Hohlfeld R, Yuki N, Dornmair K, Meinl E (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79(23):2241&#x2013;2248. https://doi.org/10.1212/WNL.0b013e31827689ad</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827689ad</ArticleId><ArticleId IdType="pubmed">23100406</ArticleId><ArticleId IdType="pmc">3542349</ArticleId></ArticleIdList></Reference><Reference><Citation>Notturno F, Di Febo T, Yuki N, Fernandez Rodriguez BM, Corti D, Nobile-Orazio E, Carpo M, De Lauretis A, Uncini A (2014) Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy. J Neuroimmunol 276(1&#x2013;2):207&#x2013;212. https://doi.org/10.1016/j.jneuroim.2014.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.09.001</ArticleId><ArticleId IdType="pubmed">25283719</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzartos JS, Zisimopoulou P, Rentzos M, Karandreas N, Zouvelou V, Evangelakou P, Tsonis A, Thomaidis T, Lauria G, Andreetta F, Mantegazza R, Tzartos SJ (2014) LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 1(2):80&#x2013;87. https://doi.org/10.1002/acn3.26</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.26</ArticleId><ArticleId IdType="pubmed">25356387</ArticleId></ArticleIdList></Reference><Reference><Citation>Liewluck T (2017) Anti-cytosolic 5&#x2b9;-nucleotidase 1A (cN1A) autoantibodies in motor neuron diseases. Neurology 89(19):2017&#x2013;2018. https://doi.org/10.1212/WNL.0000000000004610</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004610</ArticleId><ArticleId IdType="pubmed">28954884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>